ANAB
ANAPTYSBIO INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
ANAPTYSBIO INC (ANAB) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$86.83M; the largest are Izzy Englander, Ken Griffin, Renaissance Technologies. 2 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 3 added, 2 trimmed, 1 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Common-stock holders52 also report options
Congress trades0
Price$50.80vs quarter-end-24.74%
Sectors0
This quarter's moves
Top holderNew0
Added3
Trimmed / sold3
Izzy EnglanderCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $1.01M— of portfolio15,0002026 Q2
Value $722.3K— of portfolio10,7002026 Q2
Value $580.5K— of portfolio8,6002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Izzy EnglanderCALL | $1.01M | — | — |
| Ken GriffinPUT | $722.3K | — | — |
| Ken GriffinCALL | $580.5K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.